Information Journal Paper
APA:
Copy. (2019). Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP. LEUKEMIA AND LYMPHOMA, -(-), 1-13. SID. https://sid.ir/paper/733615/en
Vancouver:
Copy. Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP. LEUKEMIA AND LYMPHOMA[Internet]. 2019;-(-):1-13. Available from: https://sid.ir/paper/733615/en
IEEE:
Copy, “Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP,” LEUKEMIA AND LYMPHOMA, vol. -, no. -, pp. 1–13, 2019, [Online]. Available: https://sid.ir/paper/733615/en